Immunomodulatory functions of oral mesenchymal stem cells: Novel force for tissue regeneration and disease therapy

J Leukoc Biol. 2021 Sep;110(3):539-552. doi: 10.1002/JLB.3MR0321-766R. Epub 2021 Jun 28.

Abstract

Mesenchymal stem cells (MSCs)-based therapeutic strategies have achieved remarkable efficacies. Oral tissue-derived MSCs, with powerful self-renewal and multilineage differentiation abilities, possess the features of abundant sources and easy accessibility and hold great potential in tissue regeneration and disease therapies. Oral MSCs mainly consist of periodontal ligament stem cells, gingival mesenchymal stem cells, dental pulp stem cells, stem cells from human exfoliated deciduous teeth, stem cells from the apical papilla, dental follicle stem cells, and alveolar bone-derived mesenchymal stem. Early immunoinflammatory response stage is the prerequisite phase of healing process. Besides the potent capacities of differentiation and regeneration, oral MSCs are capable of interacting with various immune cells and function as immunomodulatory regulators. Consequently, the immunomodulatory effects of oral MSCs during damage repair seem to be crucial for exploring novel immunomodulatory strategies to achieve disease recovery and tissue regeneration. Herein, we reviewed various oral MSCs with their immunomodulatory properties and the potential mechanism, as well as their effects on immunomodulation-mediated disease therapies and tissue regeneration.

Keywords: MSCs; immune; immunomodulation; immunosuppression; regeneration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease*
  • Humans
  • Immunomodulation*
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / immunology*
  • Mouth / cytology*
  • Regeneration / physiology*